Announcements Trials
Browse Landscape

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 3Interventional 2Expanded_access 1

Sponsor

Cancer Type

CNS 3

Conditions

Glioma 3

Interventions

Magnetic Resonance Spectroscopy 9Blood Specimen Collection 9Radiotherapy 7Surveys and Questionnaires 6Surgical Procedures, Operative 4vorasidenib 3Temozolomide 3Aminolevulinic Acid 3X-Rays 2Watchful Waiting 2Polymerase Chain Reaction 2Neuropsychological Tests 2Mental Status and Dementia Tests 2Magnetic Resonance Imaging 2Fluorodeoxyglucose F18 2Diagnostic Imaging 2Cancer Vaccines 2Amplified Fragment Length Polymorphism Analysis 2vinyltriethoxysilane 1lentiviral minigene vaccine of COVID-19 coronavirus 1gadoterate meglumine 1gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate 1fluorodopa F 18 1fluarix 1apatinib 1Ultrasonography 1Transurethral Resection of Bladder 1Trail Making Test 1Tetanus Toxoid 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Glioma × vorasidenib × Clear all
NCT07547163 2026-04-23

LGG PRO's

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Recruiting
90 enrolled
CNS

Glioma

NCT07240662 2026-01-09

VIOLETA

iOMEDICO AG

Recruiting
150 enrolled
CNS

Glioma

NCT06969352 2025-05-13

VICTORIA

Servier (Tianjin) Pharmaceutical Co. LTD.

Not yet recruiting
60 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡